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Aim: Dysmorphic neurons and balloon cells in focal cortical dysplasia (FCD) reportedly show immaturity and abnormal differentiation with neuronal and glial components. Although normal-looking neurons (NL-neurons) in FCD are major constituent elements, their biological characteristics have never been identified. The aim of this study was to investigate maturation of NL-neurons with the focus on neuronal developmental lineage. Methods: Eighteen FCD surgical specimens and controls were examined immunohistochemically using the antibodies for nestin, mammalian achaete-scute complex homolog 1 (Mash1), prospero-related homeobox 1 (Prox1), neuron-specific beta-III tubulin (Tuj1) and microtubule-associated protein 2 (MAP2) of neuronal lineage, glutamic acid decarboxylase (GAD), calretinin (CR) and calbindin (CB) of interneuron markers, and glial fibrillary-acidic protein (GFAP) of glial cell marker. Additionally, we performed fluorescent-double staining with these markers, and semi-quantitative analysis. Results: NL-neurons in FCD had both mature and immature components, without interneuron components. NL-neurons in FCD showed abnormal maturation with the combined expression of MAP2 and Mash1/Prox1. Prox1-containing cell distribution in the deep layer was different from that of Mash1-containing cells in the superficial area. The MAP2-containing cell concentration decreased in the order of type I-A, I-B, II-A and II-B, but the Tuj1-containing cell concentration increased. Conclusion: These findings may reflect differences in neuronal function and expression timing in developmental stages. From the standpoint of molecular expression, abnormal maturation of NLneurons may initiate synaptic dysfunction, resulting in intractable seizures of FCD.
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observable in FCD lesions, but occasionally dysmorphic neurons or balloon cells. In the present study, we attempted to confirm that NL-neurons in FCD were in the immature stages of neuronal development.
Materials and methods

FCD surgical tissue preparation
Eighteen patients with drug-resistant epilepsy having FCD on imagings participated in this study. Their clinical features are summarized in Table 1 . Studied samples were part of the tissues removed for therapeutic reasons after careful assessment of the epileptogenic areas, determined by analysis of seizure semiology, electroencephalography, magnetic resonance imaging, fluorodeoxyglucose positron emission tomography and ictal or interictal single photon emission computed tomography. After resection, hematoxylin and eosin (HE) and Klü ver-Barrera (KB) stainings were done. The tissues diagnosed as FCD with no hippocampal sclerosis by two individual neuropathologists were divided into 4 groups by Palmini 
Normal-looking neurons
We defined normal-looking (NL) neurons with no giant cell, no dysmorphic neuron and no balloon cell, using HE and KB staining. Many NL-neurons were observed in a FCD lesion, although the characteristic marker cells of FCD were few in number in the lesion. NL-neurons were small and round, or showed pyramidal neuronlike features.
Immunohistochemistry
The serial sections were deparaffinized, rehydrated and pretreated in 0.3% H 2 O 2 for 20 min to remove endogeneous peroxidase activity. Heat-induced epitope retrieval was performed in sodium citrate buffer solution (pH 6.0) by warming up to 95 8C in a microwave oven for 10 min. Following blocking with 2% bovine albumin in phosphate-buffered saline (PBS), the sections were incubated at 4 8C for overnight with the antibodies. We used monoclonal antibodies against MAP2 (dilution of 1:100; Sigma, St. Louis, MO), Tuj1 (1:1000; R&D Systems Inc., Minneapolis, MN), nestin (1:100; Chemicon International, Temecula, CA), glutamic acid dehydroxylase (GAD) (1:1000; Biomole International, Plymouth Meeting, PA), calretinin (CR) (1:1000; Sigma), calbindin (CB) (1:1000; Sigma) and GFAP (1:1000; Sigma), as well as the polyclonal antibodies against Prox1 (1:500; Sigma) and Mash1 (1:1000; kind gift of Dr. J.E. Johnson). As secondary antibodies, horseradish peroxidase-labeled mouse-and-rabbit-IgG sera were used (Nichirei, Tokyo, Japan). The antigen-antibody complex was visualized with aminoethyl carbazole (Nichirei, Tokyo, Japan).
Slide-mounted sections were counterstained with 0.2% methyl green or hematoxylin. The stained sections were observed with a microscope (BX50; Olympus, Tokyo, Japan), digitized with a DXM1200F digital camera system (Nikon, Tokyo, Japan), and the neuronal developmental lineage of NL-neurons in FCD was evaluated.
Double labeling
To confirm the relationship between the neuron and its immaturity, double-labeling observation was performed with MAP2, Mash1, Tuj1, GFAP and myelin basic protein (MBP; 1:200; DAKO Corporation, Carpinteria, CA), as well as GAD, CR and CB. Alexafluor-488-and -568-conjugated secondary antibodies (Invitrogen Corporation, Carlsbad, CA) were applied for 1 h at room temperature, and sections were mounted in a VECTASHIELD mounting medium with DAPI (Vector Laboratories, Burlingame, CA). The fluorescent-stained sections were examined under a fluorescent microscope system (BX51 and BH2-RFL-T; Olympus) and digitized by a DP70 system (Olympus).
Counts of immunopositive cells and their comparison between FCD subtypes
Various immunopositivities of NL-neurons were observed in all cases, and the number of cells was counted in each of 5 fields at a magnification of 200 times. The number was corrected per 100 neurons in each case as the immunopositive cell concentration. Four subtypes were analyzed.
For statistical analysis, the ANOVA test was used for comparison between the subtypes. Post hoc comparisons were done with Fisher's protected least-significant difference test at a significance level of p < 0.05.
Results
All FCD lesions showed abnormal lamination of the cortices and many ectopic neurons in the white matter (Fig. 1A) . Our FCD series was composed of five type I-A, five type I-B, five type II-A and three type II-B. The immunohistochemistry is summarized in Table 1 .
In age-matched controls, MAP2-or Tuj1-containing cells were confirmed in the cortex, but Mash1-, Prox1-and nestin-containing cells were not (Table 1 and Fig. 2D1-D5 , E1-E5). However, their immunopositivities were confirmed in fetal brains (Table 1 and Fig. 2C1-C5 ). On the contrary, all FCD patients had diffusely Tuj1-and MAP2-containing neurons in the cortices and white matter (Figs. 1B, C and 2A1, A3). Tuj1-containing neurons were fewer than those of MAP2-containing neurons. Mash1-containing neurons distributed in the superficial area of the cortex and white matter (Fig. 1D) . Interestingly, Prox1-containing neurons distributed in the deep area of the cortex and white matter (Fig. 1E) . Nestincontaining cells were never observed (Fig. 2A2) . GAD-, CR-and CBcontaining cells, which were interneurons, diffusely distributed in the cortex, and became fewer in number (data not shown) as previously reported. 12, 13 From the double staining, FCD revealed MAP2-containing cells which had no glial features (Fig. 3A-F) , but showed Mash1-immunoreactivity (Fig. 3G-I ). Tuj1-containing cells also had Mash1-immunoreactivity (Fig. 3J-L (Fig. 4) . The numbers of 
M, male; F, female; y, year(s); m, month(s); d, days; CPS, complex partial seizure; GTC, generalized tonic-clonk seizure; IQ, intelligent quotient; DQ, developmental quotient; P, parietal lobe; F, frontal lobe; O, occipital lobe; T, temporal lobe; CAL, calcification(s); EN, ectopic neuron(s) in the white matter; n.d.: not described; n.s.c., no significant changes; PMG: polymicrogyria; ++, observed immunopositive neurons; +, few immunopositive neurons; À, no immunopositive neurons; TSC; tuberous sclerosis complex; HME, hemimegalencephaly. 
Discussion
Although the examined cases were few, our results indicated that NL-neurons in FCD had various developmental components with immature components, Mash1, Prox1 and Tuj1, but without interneuron components. MAP2-and Tuj1-containing cells were distributed differently in every FCD subtype, although MAP2-containing cell concentration significantly decreased in all subtypes, compared with control. This phenomenon may reflect pathogenetic differences between FCD subtypes. Type I-A, I-B, II-A and II-B show gradually severe clinical and pathological features. 4, 5 In this order, the MAP2-containing cell concentration decreased, but the Tuj1-containing cell concentration increased. This may indicate that many NL-neurons in type II-B are immature.
Dysmorphic neurons in FCD have been described as immature and undifferentiated, having both neuronal and glial components. 14 The focus of the present study was the maturation of NLneurons in FCD. The biological characteristics of NL-neurons in FCD have not been described, although they are major FCD constituent elements. NL-neurons in FCD show morphologically neuronal immaturity or abnormal migration. 15 Recent molecular neuroscience has explained mammalian neuronal lineage in detail. 16 In the first stage of neuronal development, nestin expresses in undifferentiated neuroepithelial cells. 17 As nestin, Mash1 also appears in neuronal progenitors in the neocortical ventricular zone. 11, 18 Prox1, which expresses in the neocortical subventricular zone, characterizes secondary precursor neurons. 11, 19 Both Mash1-and Prox1-containing cells are mitotically active and have transient proliferative potential. 11 After the disappearance of Mash1 and/or Prox1, Tuj1 (the earliest marker of postmitotic neuron) and MAP2 (the marker of mature neuron) express in the cortical plate. In the current study, Mash1 and Prox1 were never observed in age-matched controls. Thus, these transcriptional factors disappeared in the postnatal cortex. On the basis of our results, it may be speculated that NL-neurons in FCD can be characterized not only by their developmental immaturity but also by expression of neuronal mature-markers such as MAP2. In NL-neurons in FCD, both transcription factors may have irregular functions, while Mash1 and Prox1 downstream genes are currently unknown. Although Mash1 obviously induces a neuronal trait and plays an important role in neuronal maturation, further study is warranted to understand the molecular mechanism of the mixture of various developmental stage markers in NL-neurons in FCD. Moreover, type II-A has a relatively larger number of Prox1-containing cells than the other types. This may reflect neuronal undifferentiation and lead to neuronal dysmorphism. Mash1 expresses in both projection neurons and interneurons. To clarify which type of neuron Mash1 expressed in FCD, we checked the colocalizations of Mash1 and MAP2/Tuj1, and Mash1 and GAD/CR/CB, interneuron markers. Mash1 colocalized with MAP2 and Tuj1, but not with interneuron markers. This indicates that Mash1-containing cells have immature projection neurons. One can speculate that Mash1-containing cells of FCD may be projection neurons and originate from neuronal precursors in the neocortical ventricular zone.
Interestingly, Prox1-labeled cells exist in the neocortical subventricular zone, the starting point for radial migration of predictable pyramidal neurons. 11 The Prox1-containing cell distribution in the deep area of the cortex and white matter, was different from that of Mash1-containing cells, predominantly in the superficial area of the cortex. This may reflect that both labeled cells have a different function and birth timing. In summary, epileptogenesis of FCD has been discussed in terms of morphological abnormalities and dysfunction of synapse, as well as the dysregulation of neuronal inhibition associated with abnormal distribution of interneurons. 20, 21 Here, we provided data on direct evidence for the dysmaturation of NL-neurons in FCD from the standpoint of molecular expression. This maturational abnormality may initiate synaptic dysfunction, resulting in characteristic symptoms of FCD and intractable seizures.
